Widely Used Cholesterol-Lowering Drug May Prevent Progression of Parkinson’s Disease

Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson’s disease from progressing further.

Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson’s disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.

“Statins are one of the most widely used cholesterol-lowering drugs throughout the world,” said study author Kalipada Pahan, PhD, professor of neurological sciences at Rush. “This may be a safer approach to halt the disease progression in Parkinson’s patients.”

Read more…..

Comments

Comments are closed.